Akeso Biomedical is developing a new generation of compounds,
known as Fe3C, with broad-spectrum activity to fight bacterial infections,
and prevent foodborne illnesses.

The company’s proprietary technology is being used initially to develop a feed additive designed to prevent food poisoning by Campylobacter, a bacteria that causes more cases of foodborne illness in the EU than Salmonella, E. coli, and Listeria combined.